The brains of children with gender dysphoria react to androstadienone, a musky-smelling steroid produced by men, in a way typical of their biological sex, but after puberty according to their experienced gender, finds a study for the first time in the open-access journal Frontiers in Endocrinology.
Around puberty, the testes of men start to produce androstadienone, a breakdown product of testosterone. Men release it in their sweat, especially from the armpits. Its only known function is to work like a pheromone: when women smell androstadienone, their mood tends to improve, their blood pressure, heart rate, and breathing go up, and they may become aroused.
Previous studies have shown that, in heterosexual women, the brain region that responds most to androstadienone is the hypothalamus, which lies just above the brainstem and links the nervous system to the hormonal system. In men with gender dysphoria (formerly called gender identity disorder) – who are born as males, but behave as and identify with women, and want to change sex – the hypothalamus also reacts strongly to its odor. In contrast, the hypothalamus of heterosexual men hardly responds to it.
Girls without gender dysphoria before puberty already show a stronger reaction in the hypothalamus to androstadienone than boys, finds a new study by Sarah Burke and colleagues from the VU University Medical Center of Amsterdam, the Netherlands, and the University of Liège, Belgium.
The researchers used neuroimaging to also show for the first time that in prepubescent children with gender dysphoria, the hypothalamus reacts to the smell of androstadienone in a way typical of their biological sex. Around puberty, its response shifts, and becomes typical of their experienced gender.
The reaction to the smell of androstadienone in the hypothalamus of 154 children and adolescents, including girls and boys, both before (7 to 11-year-old) and after puberty (15 to 16-year-old), of whom 74 had been diagnosed with gender dysphoria.
Results showed that the hypothalamus was more responsive to androstadienone in 7 to 11-year-old girls than in boys, both without gender dysphoria, although not yet as much as in adolescent girls. This means that the greater receptiveness of women to its odor already exists before puberty, either as an inborn difference or one that arises during early childhood.
Before puberty, the hypothalamus of boys with gender dysphoria hardly reacted to the odor, just as in other boys. But this changed in the 15 to 16-year-olds: the hypothalamus of adolescent boys with gender dysphoria now lit up as much as in heterosexual women, while the other adolescent boys still did not show any reaction. Adolescent girls with gender dysphoria showed the same reaction to androstadienone in their hypothalamus as is typical for heterosexual men.
These results suggest that as children with gender dysphoria grow up, their brain naturally undergoes a partial rewiring, to become more similar to the brain of the opposite sex – so corresponding to their experienced gender.
Note to Editors
1. For a copy of the embargoed paper, please contact Gozde Zorlu: press@frontiersin.org
2. Article title: Hypothalamic response to the chemo-signal androstadienone in gender dysphoric children and adolescents
Journal: Frontiers in Endocrinology
For online articles, please include a link to the article, which will appear on the following active URL: http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00060/abstract
3. Contacts
Gozde Zorlu
Communications Manager
Frontiers
Switzerland
E-mail: press@frontiersin.org
4. About Frontiers
Frontiers is a community-driven open-access publisher and research networking platform. Launched and run by scientists since 2007, Frontiers empowers researchers to advance the way science is peer-reviewed, evaluated, published, communicated, and shared in the digital era. Frontiers drives innovations in peer-review, article level metrics, post publication review, democratic evaluation, research networking and a growing ecosystem of open-science tools. Frontiers joined the Nature Publishing Group family in 2013. The "Frontiers in" journal series has published 20,000 peer-reviewed articles across 46 journals, which receive 6 million monthly views, and are supported by over 140,000 editors, reviewers and authors worldwide. For more information, visit: http://www.frontiersin.org
Journal
Frontiers in Endocrinology